BTBee‐Choo Tai

Bee‐Choo Tai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bee‐Choo Tai has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • David Machin

    National Cancer Centre, Division of Clinical Trials and Epidemiological Sciences, 11 Hospital Drive, Singapore 169610

    3 shared publications
  • Ian R. White

    Affiliation MRC Clinical Trials Unit at University College London, London, United Kingdom

    2 shared publications
  • Val Gebski

    NHMRC Clinical Trials Centre, Level 5, Building F, 88 Mallett St, Locked Mail Bag 77, Camperdown NSW 2050, Australia

    2 shared publications
  • Alexander Peregoudov

    Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland

    1 shared publication

Latest Publications

  • On the issue of ‘multiple’ first failures in competing risks analysis

    by Bee‐Choo Tai, Ian R White, Val Gebski, David Machin

    In the classical competing risks framework, a subject may only fail from one of several distinct causes. However, in the context of cancer clinical trials where information on first relapse is usually of interest, there could be occasions when ‘multiple’ first recurrences are identified at a particular follow‐up. In this instance, the competing risks methodology cannot be implemented without first tackling the issue of ‘tied’ first failure. When the tied events were substantial, Arriagadaet al. regarded each competing failure separately, and combined the ‘simultaneous’ failures into a single category for analysis. This paper describes two other methods of accounting for ‘multiple’ failures. First, the ties were dealt with by applying a weighting factor which was equal to the reciprocal of the number of ties. We also considered ‘jittering’ which randomly adds or subtracts a small number to each ‘tied’ event time to randomly break the tie. As illustrated using the data obtained from a randomized trial of patients with operable osteosarcoma, the estimates based on Arriagada's approach have larger standard errors. Estimates from the other alternative methods were similar. Multiple jittering has the advantage of wide applicability in any situation of tied survival times. However, it takes a longer computer running time, especially when the number of replicates is large. The weighted Cox approach is the method of choice where statistical software allows its implementation without extra programming effort. Copyright © 2002 John Wiley & Sons, Ltd.


  • A competing risk approach to the analysis of trials of alternative intra‐uterine devices (IUDs) for fertility regulation

    by Bee‐Choo Tai, Alexander Peregoudov, David Machin

    The methods of survival analysis have had a profound influence on the way that studies concerned with the safety and efficacy of intra‐uterine devices (IUDs) for fertility control have been designed, conducted, analysed and reported. For example, the Kaplan–Meier technique has been used to summarize the results of controlled clinical trials of alternative devices and the logrank test used to make any comparisons. A particular feature of IUD studies is the large number of possible causes of failure (reasons for discontinuation of the device). These lead to considerations of competing risks, where in this framework, the discontinuations are considered as competing causes of contraceptive failure. In this context, we compare the net and crude probability estimates of discontinuation rates using continuous time and argue for the routine use of the latter. We use data from a randomized multi‐centre trialon the long‐term safety and efficacy of two IUDs, TCu220C and TCu380A, for illustration. Copyright © 2001 John Wiley & Sons, Ltd.


  • Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches

    by Bee‐Choo Tai, David Machin, Ian White, Val Gebski

    In failure time studies involving a chronic disease such as cancer, several competing causes of mortality may be operating. Commonly, the conventional statistical technique of Kaplan–Meier, which is only meaningfully interpreted by assuming independence of failure types and the censoring mechanism, is employed in clinical research involving competing risks data. Some authors have advocated the use of a cause‐specific cumulative incidence function which takes into account the existence of other events within a competing risks framework, without making any assumption about independence. Lunn and McNeil have proposed an approach based on an extension of the Cox proportional hazards regression, which enables direct comparisons between failure types. We have extended this approach to estimate cause‐specific cumulative incidence. As it is often not easy to follow competing risks methodology in the literature, this paper sets out systematically the assumptions made and the steps taken to implement four different methods of analysing competing risks data using cumulative incidence rates or the Kaplan–Meier estimates of cause‐specific failure probabilities. The data obtained from a randomized trial of patients with osteosarcoma were used to compare these four approaches. As illustrated using the osteosarcoma data, the estimates of the classical Kaplan–Meier methods have larger numerical values than the cause‐specific cumulative incidence. On the other hand, estimates of the cause‐specific cumulative incidence rates from the conventional method and the modified Cox method are highly comparable. Copyright © 2001 John Wiley & Sons, Ltd.